Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

4DX PEER ANALYSIS

4DMEDICAL Ltd — metric-by-metric comparison with peers and the industry median

4DX4DMEDICAL Ltd

🇦🇺 Australia · AU · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
4DXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
4DX+1,741.7%AHCO+9.7%IART+36.9%ATEC-14.2%INSP-60.5%IRMD+72.2%
Year-to-Date (YTD)
4DX+12.5%AHCO+1.9%IART+40.6%ATEC-55.4%INSP-45.7%IRMD+3.5%
1-Year
Split-adjusted
4DX+1,741.7%COH-56.9%
Year-to-Date (YTD)
4DX+12.5%COH-50.6%

Key Metric Comparison

P/E

Lower is better
4DX—AHCO—IART—ATEC—INSP10.96IRMD54.64Median 27.09

ROE

Higher is better
4DX—AHCO-5.2%IART-38.6%ATEC—INSP18.4%IRMD25.0%Median -8.6%

Net Margin

Higher is better
4DX-3,684.6%AHCO-2.8%IART-30.1%ATEC-15.9%INSP14.3%IRMD27.4%Median -5.7%

Revenue Growth

Higher is better
4DX-26.0%AHCO8.8%IART1.2%ATEC22.5%INSP8.9%IRMD14.8%Median 7.4%

P/E

Lower is better
4DX—COH24.11Median 27.09

ROE

Higher is better
4DX—COH18.1%Median -8.6%

Net Margin

Higher is better
4DX-3,684.6%COH14.6%Median -5.7%

Revenue Growth

Higher is better
4DX-26.0%COH2.0%Median 7.4%

All Metrics

Valuation
Metric4DXAHCOIARTATECINSPIRMDInd. Median
P/E————10.96●54.6427.09
P/B-77.13●0.911.2979.151.8113.102.51
EV/EBITDA—7.20●——14.77—15.39
P/S252.890.48●0.821.841.5714.952.62
Financial Health
Metric4DXAHCOIARTATECINSPIRMDInd. Median
Current Ratio6.570.923.381.906.347.13●3.28
Debt/Equity-22.6%●132.8%195.6%3,303.4%3.7%—44.7%
NetDebt/EBITDA0.714.22-6.13-341.81●-3.17—0.82
Profitability
Metric4DXAHCOIARTATECINSPIRMDInd. Median
Net Margin-3,684.6%-2.8%-30.1%-15.9%14.3%27.4%●-5.7%
ROE—-5.2%-38.6%—18.4%25.0%●-8.6%
ROA-264.3%-1.8%-21.8%-15.8%16.0%21.8%●-6.4%
EBITDA Margin-818.8%16.2%-17.6%-0.2%8.8%37.4%●5.2%
Growth + Dividend
Metric4DXAHCOIARTATECINSPIRMDInd. Median
Rev. Growth-26.0%8.8%1.2%22.5%●8.9%14.8%7.4%
NI Growth————97.2%●19.3%16.7%
Div. Yield—————0.8%1.1%
Payout—————65.4%39.0%
Valuation
Metric4DXCOHInd. Median
P/E—24.1127.09
P/B-77.13●4.302.51
EV/EBITDA—15.1115.39
P/S252.893.53●2.62
Financial Health
Metric4DXCOHInd. Median
Current Ratio6.57●2.463.28
Debt/Equity-22.6%●22.1%44.7%
NetDebt/EBITDA0.710.42●0.82
Profitability
Metric4DXCOHInd. Median
Net Margin-3,684.6%14.6%●-5.7%
ROE—18.1%-8.6%
ROA-264.3%12.4%●-6.4%
EBITDA Margin-818.8%24.0%●5.2%
Growth + Dividend
Metric4DXCOHInd. Median
Rev. Growth-26.0%2.0%●7.4%
NI Growth—-6.8%16.7%
Div. Yield—3.6%1.1%
Payout—81.5%39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on 4DX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.